Atlas Trials

Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer

Clinical trial NCT06121505 · RECRUITING

Trial details

NCT number
NCT06121505
Sponsor
Sichuan University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Squamous Cell Carcinoma
Start date
2024-03-01
Primary completion
2027-02-28
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.